A quantitative theory of solid tumor growth, metabolic rate and vascularization

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Herman, Alexander B ^a,c,d   van Savage, M ^b,c,d   West, Geoffrey B ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SANTA FE INSTITUTE   (United States)

^d LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; BLOOD VESSEL PARAMETERS; BLOOD VESSEL SIZE; CAPILLARY DENSITY; CELL GROWTH; CELL METABOLISM; CELL VIABILITY; GROWTH RATE; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MEDICAL RESEARCH; METABOLIC RATE; MITOSIS; PREDICTION; QUANTITATIVE ANALYSIS; THEORY; TUMOR BLOOD FLOW; TUMOR GROWTH; TUMOR NECROSIS; TUMOR VASCULARIZATION; ALGORITHM; ANIMAL; AUDIOVISUAL EQUIPMENT; BIOLOGICAL MODEL; BLOOD FLOW VELOCITY; CHEMISTRY; HUMAN; METABOLISM; NECROSIS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; REPRODUCIBILITY;

ANIMALIA;

OXYGEN;

ALGORITHMS; ANIMALS; BLOOD FLOW VELOCITY; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MITOSIS; MODELS, ANATOMIC; MODELS, BIOLOGICAL; NECROSIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; REPRODUCIBILITY OF RESULTS;

EID: 80053310398     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022973     Document Type: Article

References (58)

1. West GB, Brown JH, Enquist BJ, (1997) A general model for the origin of allometric scaling laws in biology. Science 276: 122-126.
2. West GB, Woodruff W, Brown JH, (2002) Allometric scaling of metabolic rate from molecules and mitochondria to cells and mammals. Proc Natl Acad Sci USA 99: 2473-2478.
3. Savage V, Bentley L, Enquist B, Sperry J, Smith D, et al. (2010) Hydraulic trade-offs and space filling enable better predictions of vascular structure and function in plants. Proc Natl Acad Sci USA 107: 22722-22727.
4. Zamir M, (2000) Scaling in Biology New York, NY Oxford University Press pp. 129-145 chapter 8.
5. Huo Y, Kassab GS, (2006) Pulsatile blood ow in the entire coronary arterial tree: theory and experiment. Am J Physiol-Heart C 291: H1074-H1087.
6. Kassab GS, (2006) Scaling laws of vascular trees: of form and function. Am J Physiol-Heart C 290: H894-H903.
7. Spencer S, Gerety R, Pienta K, Forrest S, (2006) Modeling somatic evolution in tumori- genesis. PLoS Comput Biol 18: e108.
8. Gatenby RA, Maini PK, (2003) Cancer summed up. Nature 421: 321.
9. Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, et al. (1997) Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 94: 8761-8766.
10. Macklin P, McDougall S, Anderson A, Chaplain M, Cristini V, et al. (2009) Multiscale modelling and nonlinear simulation of vascular tumour growth. J Math Biol 58: 765-798.
11. Gevertz J, Torquato S, (2006) Modeling the effects of vasculature evolution on early brain tumor growth. J Theor Biol 243: 517-31.
12. Chaplain M, McDougall S, Anderson A, (2006) Mathematical modeling of tumor-induced angiogenesis. Annu Rev Biomed Eng 8: 233-257.
13. Rejniak KA, Anderson ARA, (2011) Hybrid models of tumor growth. WIREs Syst Biol Med 3: 115-125.
14. Anderson A, (2005) A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math Med Biol 22: 163-186.
15. West GB, Brown JH, Enquist BJ, (2001) A general model for ontogenetic growth. Nature 413: 628-631.
16. Guiot C, Degiorgis P, Delsanto P, Gabriele P, Deisboeck T, (2003) Does tumor growth follow a "universal law"? J Theor Biol 225: 147-151.
17. van Leeuwen I, Zonneveld C, Kooijiman S, (2003) The embedded tumour: host physiology is important for the evaluation of tumour growth. Br J Cancer 89: 2254-2263.
18. Friebores B, Zheng X, Sun C, Tromberg B, Gatenby R, et al. (2006) Integrated computational/experimental model of tumor invasion. Cancer Res 66: 1597-1604.
19. Kallinowsk F, Schlenger K, Runkel S, Kloes M, Stohrer M, et al. (1984) Blood ow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res 49: 3759-3764.
20. Gullino PM, Grantham FH, (1961) Studies on the exchange of uids between host and tumor. ii. the blood flow of hepatomas and other tumors in rats and mice. J Natl Cancer Inst 27: 1465-1491.
21. Less JR, Skalak TC, Sevick EM, Jain RK, (1991) Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res 51: 265-273.
22. Craciunescu OI, Das S, Clegg S, (1999) Dynamic contrast-enhanced MRI and fractal characteristics of percolation clusters in two-dimensional tumor blood perfusion. J Biomech Eng 121: 480-486.
23. Gazit Y, Baish JW, Safabakhsh N, Leunig M, Baxter LT, et al. (1997) Fractal characteristics of tumor vascular architecture during tumor growth and regression. Microcirculation 4: 395-402.
24. Sabo E, Boltenko A, Sova Y, Stein A, Kleinhaus S, et al. (2001) Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res 7: 533-537.
25. Savage V, Deeds E, Fontana W, (2008) Sizing up allometric scaling theory. PLoS Comput Biol 4: e1000171.
26. Guiot C, Delsanto P, Carpinteri A, Pugno YN, Mansury, Deisboeck T, (2006) The dynamic evolution of the power exponent in a universal growth model of tumors. J Theor Biol 240: 459-463.
27. Baish J, Gazit Y, Berk D, Nozue M, Baxter L, et al. (1996) Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model. Microvasc Res 51: 327-346.
28. Spencer RP, (1969) Blood flow in transplanted tumors: quantitative approaches to ra- dioistopic studies. Yale J Biol Med 43: 22-30.
29. Rogers W, (1967) Tissue Blood Flow in Transplantable Tumors of the Mouse and Hamster. Ph.D. thesis, University of Minnesota.
30. Lyng H, Skretting A, Rofstad EK, (1992) Blood flow in six human melanoma xenograft lines with different growth characteristics. Cancer Res 52: 584-592.
31. Hilmas DE, Gillette EL, (1973) Morphometric analysis of the microvasculature of tumors during growth and after x-irradiation. Cancer 33: 103-110.
32. Steel GG, (1980) Species-dependent growth patterns for mammalian neoplasms. Cell Tissue Kinet 13: 451-453.
33. Bassukas ID, (1993) Evidence for a narrow range of growth patterns of malignant tumors and embryos of different species. Naturwissenschaften 80: 366-368.
34. Chaplain MA, (2000) Mathematical modelling of angiogenesis. J Neurooncol 50: 37-51.
35. Gullino PM, Grantham FH, (1964) The vascular space of growing tumors. Cancer Res 24: 1727-1732.
36. Sevick EM, Jain RK, (1989) Geometric resistance to blood flow in solid tumors perfused ex vivo: Effects of tumor size and perfusion pressure. Cancer Res 49: 3506-3512.
37. Benjamin L, Keshet E, (1997) Conditional switching of vascular endothelial growth factor (vegf) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by vegf withdrawal. Proc Natl Acad Sci USA 94: 8761-8766.
38. Leu A, Berk D, Lymboussaki A, Alitalo K, Jain R, (2000) Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60: 4324-4327.
39. Brunton T, Wheldon T, (1978) Characteristic species dependant growth patterns of mammalian neoplasms. Cell Tissue Kinet 11: 161-175.
40. Steel GG, (1977) Growth kinetics of tumours Clarendon Press.
41. Kansal AR, Torquato S, Harsh GR, Chiocca EA, Deisboeck TS, (2000) Simulated brain tumor growth using a three-dimensional cellular automaton. J Theor Biol 203: 367-382.
42. Skehan P, (1986) On the normality of growth dynamics of neoplams in vivo: A database analysis. Growth 50: 496-515.
43. Zimmer C, The mere existence of whales. Available: http://blogs.discovermagazine.com/loom/2011/02/28/the-mere-existence-of-whales. Accessed 2011.
44. DeGregori J, (2011) Evolved tumor suppression: why are we so good at not getting cancer? Cancer Res 71: 3739-3744.
45. Caulin A, Maley C, (2011) Peto's paradox: evolution's prescription for cancer prevention. Trends Ecol Evol 26: 175-182.
46. Hanahan D, Weinberg R, (2011) Hallmarks of cancer: the next generation. Cell 44: 646-674.
47. Savage V, Allen A, Brown J, Gillooly J, Herman A, et al. (2007) Scaling of number, size, and metabolic rate of cells with body size in mammals. Proc Natl Acad Sci USA 104: 4718-23.
48. Gillooly J, Allen A, West G, Brown J, (2004) The rate of DNA evolution: effects of body size and temperature on the molecular clock. Proc Natl Acad Sci USA 102: 140-145.
49. Schmidt-Nielsen K, (1984) Scaling. Why is animal size so important? Cambridge University Press.
50. Gevertz J, Torquato S, (2009) Growing heterogeneous tumors in silico. Phys Rev E 80: 051910-051922.
51. Hori K, Suzuki M, Tanda S, Saito S, (1991) Characterization of heterogeneous distribution of tumor blood ow in the rat. Jpn J Cancer Res 82: 109-111.
52. Castorina P, Carco D, Guiot C, Deisboeck T, (2009) Tumor growth instability and its implications for chemotherapy. Cancer Res 69: 8507-8515.
53. Jain RK, (2005) Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 307: 58-62.
54. Tannock IF, Hill R, (1998) The Basic Science of Oncology McGraw-Hill.
55. Jain RK, (1996) Delivery of molecular medicine to solid tumors. Science 271: 1079-1080.
56. Baxter L, Zhu H, Mackensen D, Butler W, Jain R, (1995) Biodistribution of monoclonal antibodies: scale-up from mouse to human using a physiologically based pharmacokinetic model. Cancer Res 20: 4611-4622.
57. Less JR, Posner MC, Skalak TC, Wolmark N, Jain RK, (1997) Geometric resistance and microvascular network architecture of human colorectal carcinoma. Microcirculation 4: 25-33.
58. Baker GM, Goddard HL, Clarke MB, Whimster WF, (1990) Proportion of necrosis in transplanted murine adenocarcinoma and its relationship to tumor growth. Growth, Development and Aging 54: 85-93.